[go: up one dir, main page]

WO2008036733A3 - Methods for treatment of vesicle transport disorders - Google Patents

Methods for treatment of vesicle transport disorders Download PDF

Info

Publication number
WO2008036733A3
WO2008036733A3 PCT/US2007/078882 US2007078882W WO2008036733A3 WO 2008036733 A3 WO2008036733 A3 WO 2008036733A3 US 2007078882 W US2007078882 W US 2007078882W WO 2008036733 A3 WO2008036733 A3 WO 2008036733A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
treatment
vesicle transport
transport disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/078882
Other languages
French (fr)
Other versions
WO2008036733A2 (en
Inventor
Christine Klein
Andrew D Gassman
Leena Bhoite
John Manfredi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myriad Genetics Inc
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of WO2008036733A2 publication Critical patent/WO2008036733A2/en
Publication of WO2008036733A3 publication Critical patent/WO2008036733A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to methods of treating diseases and disorders responsive to the modification of vesicle transport comprising administering to a subject in need thereof an effective amount of a compound according to Formulae (I-V) as defined herein.
PCT/US2007/078882 2006-09-19 2007-09-19 Methods for treatment of vesicle transport disorders Ceased WO2008036733A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82613906P 2006-09-19 2006-09-19
US60/826,139 2006-09-19

Publications (2)

Publication Number Publication Date
WO2008036733A2 WO2008036733A2 (en) 2008-03-27
WO2008036733A3 true WO2008036733A3 (en) 2008-06-26

Family

ID=39201236

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/078882 Ceased WO2008036733A2 (en) 2006-09-19 2007-09-19 Methods for treatment of vesicle transport disorders

Country Status (1)

Country Link
WO (1) WO2008036733A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2244703B1 (en) * 2007-12-21 2011-09-28 Horizon Pharma AG Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies
BR112012024247A2 (en) 2010-04-01 2016-07-12 Chiesi Farma Spa crystalline polymorphs, acid salt and pharmaceutical composition
CA2801449A1 (en) 2010-06-04 2011-12-08 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
GB2485169A (en) * 2010-11-03 2012-05-09 Univ Jw Goethe Frankfurt Main (R)-flurbiprofen for use in the treatment of multiple sclerosis
CN112107599B (en) * 2020-08-14 2022-06-21 深圳市弘际生物科技有限责任公司 Application of stem cell exosome in preparation of medicine for treating overactive bladder syndrome

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064771A2 (en) * 2003-01-14 2004-08-05 Merck & Co., Inc. Geminally di-substituted nsaid derivatives as abeta 42 lowering agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064771A2 (en) * 2003-01-14 2004-08-05 Merck & Co., Inc. Geminally di-substituted nsaid derivatives as abeta 42 lowering agents

Also Published As

Publication number Publication date
WO2008036733A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2007136759A3 (en) Method for the treatment and prevention of ocular disorders
WO2007133637A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2006078463A3 (en) Method for treating cardiovascular disease
WO2006113942A3 (en) Method of inhibiting cathepsin activity
WO2007112052A3 (en) Formulations and methods for vascular permeability-related diseases or conditions
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
WO2008050329A3 (en) Novel sirnas and methods of use thereof
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2009027820A3 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
WO2007140002A3 (en) Method for treating non-hodgkin's lymphoma
GB0718905D0 (en) Methods, compositions and formulations for the treatment of thyroid eye disease
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
WO2008089201A3 (en) Heterocyclic-substituted piperidine as orl-1 ligands
WO2007100758A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
WO2007106884A3 (en) Methods of treating muscular wasting diseases using nf-kb activation inhibitors
WO2007022408A3 (en) Combination methods of saha and targretin for treating cancer
WO2008016640A3 (en) Use of poloxamer for the prevention and/or treatment of heart failure
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2008036733A3 (en) Methods for treatment of vesicle transport disorders
WO2006047631A3 (en) Anti-mitotic anti-proliferative compounds
WO2006055352A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07842771

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07842771

Country of ref document: EP

Kind code of ref document: A2